Skip to main content
Premium Trial:

Request an Annual Quote

Biomeme, LumiraDx PCR Coronavirus Tests Get FDA Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by Biomeme and LumiraDx.

The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is designed to detect the virus' ORF1ab and S genes in nasopharyngeal, nasal, and oropharyngeal swab specimens, as well as nasopharyngeal wash/aspirate or nasal aspirate specimens.

The test uses Biomeme's M1 Sample Prep Cartridge for RNA extraction and runs on the Philadelphia-based company's Franklin portable, handheld PCR instrument using its three-well Go-Strips. The test can also be run using Biomeme's 96-well Go Plates on Bio-Rad's CFX96 or Thermo Fisher Scientific's Applied Biosystems QuantStudio 5 RT-PCR systems.

In May, the FDA granted EUA for an RT-PCR SARS-CoV-2 test from One Health Laboratories that runs on the Franklin instrument.

Waltham, Massachusetts-based LumiraDx's SARS-CoV-2 RNA STAR assay is designed to detect the ORF1a gene of the virus in upper respiratory and bronchoalveolar lavage specimens.

Nucleic acid extraction is performed using Qiagen's QIAsymphony DSP Virus/Pathogen Kit and automated QIAsymphony SP instrument or manually using either Thermo Fisher's MagMax Viral/Pathogen Nucleic Acid Isolation Kit or Qiagen's QIAamp Viral RNA Mini Kit. The test can run on a variety of instruments including Roche's LightCycler 480 II, Thermo Fisher's Applied Biosystems 7500 Fast Dx and QuantStudio 5, and Agilent's AriaMx and Stratagene Mx3005P.

Both tests may be used by any lab CLIA-certified to perform high-complexity testing, the FDA said.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.